SARS-CoV Peptide Antigen I

VLNDILSRL is a SARS-CoV spike-derived HLA-A2-associated T-cell epitope. It has been used in peptide-MHC binding and virus-specific CD8 T-cell studies and the sequence is conserved in the corresponding SARS-CoV-2 spike region.

• viral immunology and T-cell research
• epitope mapping and antigen presentation
• cell-penetrating peptide studies
• host-pathogen interaction research

Exact residue boundaries, fluorescent labels, species origin and HLA/MHC context are integral to reagent identity. These products are intended for research use and should be matched to the specific assay design.

1. Selected publication/search record